课题基金 / 基金详情

Phylogenetic clustering of surveillance drug resistance mutations in HIV-1 among patients naïve to highly active antiretroviral therapy (HAART) and those who are non-adherent to treatment

Phylogenetic clustering of surveillance drug resistance mutations in HIV-1 among patients naïve to highly active antiretroviral therapy (HAART) and those who are non-adherent to treatment
未接受高效抗逆转录病毒治疗 (HAART) 和不坚持治疗的患者中 HIV-1 耐药突变监测的系统发育聚类
批准号：
367258
负责人：
McLaughlin Angela M
金额：
$1.27万
依托单位：
University of British Columbia
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-12-01 至 2017-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=367258&lang=en
关键词：
Acquired Immune Deficiency Syndrome (Aids) Downtown Eastside (Dtes) Vancouver Genomic Epidemiology Highly Active Antiretroviral Therapy (Haart) Human Immunodeficiency Virus (Hiv) Infectious Disease Transmission Naive Patients Phylogenetic Clusterin

项目摘要

项目成果

McLaughlin Angela M的其他基金

相关文献

中文摘要
翻译
高效抗逆转录病毒疗法（HAART）有助于延长人类免疫缺陷病毒（HIV）感染者的生存时间，并阻止其发展为获得性免疫缺陷疾病。HAART是一种定制的抗逆转录病毒药物组合
英文摘要
Highly active antiretroviral therapy (HAART) has helped to prolong survival for people living with human immunodeficiency virus (HIV) and hamper its progression to acquired immunodeficiency disease. HAART is a customized combination of antiretroviral drug
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Systematic evaluation and optimization of HIV transmission models for phylogenetic cluster identification
  • 批准号：
    417285
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $7.65万
  • 财政年份：
    2019
  • 负责人：
    McLaughlin Angela M
  • 依托单位：
    University of British Columbia
Epidemiological Correlates of HIV Phylogenetic Diversification Rate in British Columbia
  • 批准号：
    399960
  • 项目类别：
  • 资助金额：
    $0.11万
  • 财政年份：
    2019
  • 负责人：
    McLaughlin Angela M
  • 依托单位：
    University of British Columbia